Liu et al. [64] used CXCR4/TRAIL-enriched small EVs obtained from mesenchymal stem cells as cooperative agents with carboplatin against the cerebral metastases of breast cancer in vivo, improving the efficacy of chemotherapy. Here, CXCR4 is linked to breast cancer.